7.92

0.00% 0.00

Instil Bio Inc (TIL)

Overview News Price History Option Chain Financials Discussions Forecast

Instil Bio Inc stock is traded at $7.92, with a volume of 28,473. It is up +0.00% in the last 24 hours and down -1.86% over the past month. Instil Bio Inc is a clinical-stage biopharmaceutical company focused on developing a cell therapy pipeline of autologous tumor infiltrating lymphocyte, or TIL, therapies for the treatment of patients with cancer. It is also engaged in developing a novel class of genetically engineered TIL therapies using its Co-Stimulatory Antigen Receptor, or CoStAR, platform. Its pipeline includes ITIL-306 which expresses a CoStAR molecule designed to recognize, a tumor-associated antigen that is expressed on numerous solid tumors, including ovarian cancer, uterine cancer, NSCLC, and renal cancer.

Previous Close:

$7.92

Open:

$7.95

24h Volume:

28,473

Relative Volume:

1.08

Market Cap:

$53.71M

Revenue:

Net Income/Loss:

$-71.37M

P/E Ratio:

-0.7348

EPS:

-10.7782

Net Cash Flow:

$-46.62M

1W Performance:

-1.98%

1M Performance:

-1.86%

6M Performance:

-28.78%

1Y Performance:

-76.86%

1-Day Range:

$7.8485

$7.9601

1-Week Range:

$7.8485

$8.15

52-Week Range:

$5.67

$35.00

Instil Bio Inc Stock (TIL) Company Profile

Name

Instil Bio Inc

Sector

Healthcare (1104)

Industry

Biotechnology (621)

Phone

(972) 499-3350

Address

3963 MAPLE AVENUE, DALLAS

Employee

Twitter

Next Earnings Date

2026-05-19

Latest SEC Filings

TIL's Discussions on Twitter

Compare TIL vs VRTX, REGN, ARGX, ALNY, RVMD

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
TIL Instil Bio Inc	7.92	53.71M	0	-71.37M	-46.62M	-10.78
VRTX Vertex Pharmaceuticals Inc	450.46	114.33B	12.34B	4.34B	3.71B	16.87
REGN Regeneron Pharmaceuticals Inc	614.98	64.47B	14.92B	4.42B	3.79B	41.04
ARGX Argen X Se Adr	884.20	54.99B	4.16B	1.29B	734.26M	19.58
ALNY Alnylam Pharmaceuticals Inc	287.80	38.42B	4.29B	577.22M	641.34M	4.2086
RVMD Revolution Medicines Inc	160.06	34.03B	742.00K	-1.37B	-1.07B	-7.0731

Instil Bio Inc Stock (TIL) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Jan-07-26	Downgrade	H.C. Wainwright	Buy → Neutral
Jan-06-26	Downgrade	Robert W. Baird	Outperform → Neutral
Jan-07-25	Upgrade	Jefferies	Hold → Buy
Nov-04-24	Initiated	JMP Securities	Mkt Perform
Apr-12-24	Downgrade	Jefferies	Buy → Hold
Nov-01-22	Downgrade	Cowen	Outperform → Market Perform
Nov-01-22	Downgrade	Truist	Buy → Hold
Aug-13-21	Initiated	Robert W. Baird	Outperform
Apr-13-21	Initiated	Cowen	Outperform
Apr-13-21	Initiated	Morgan Stanley	Equal-Weight
Apr-13-21	Initiated	Truist	Buy

View All

Instil Bio Inc Stock (TIL) Latest News

Jun 12, 2026

Instil Bio (TIL) director awarded stock options for 6,500 shares at $7.93 - Stock Titan

Jun 12, 2026

Instil Bio (NASDAQ: TIL) director receives grant of 6,500 stock options - Stock Titan

Jun 12, 2026

Instil Bio (TIL) director awarded 6,500 stock options at $7.93 strike - Stock Titan

Jun 12, 2026

Instil Bio (TIL) director Gwendolyn Binder awarded 6,500 stock options at $7.93 - Stock Titan

Jun 12, 2026

Jun 11, 2026

Instil Bio Shareholders Back Directors and Auditor at Meeting - TipRanks

Jun 11, 2026

[8-K] Instil Bio, Inc. Reports Material Event - Stock Titan

Jun 11, 2026